May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Proinflammatory Cytokines Upregulate Human ß-Defensin-2 Expression in Conjunctival Epithelial Cells: Relevance to Dry Eye Disease
Author Affiliations & Notes
  • S. Narayanan
    College of Optometry, Univ of Houston, Houston, TX, United States
  • A.M. McDermott
    College of Optometry, Univ of Houston, Houston, TX, United States
  • Footnotes
    Commercial Relationships  S. Narayanan, None; A.M. McDermott, None.
  • Footnotes
    Support  NIH EY13175; Texas ARP
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 2490. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. Narayanan, A.M. McDermott; Proinflammatory Cytokines Upregulate Human ß-Defensin-2 Expression in Conjunctival Epithelial Cells: Relevance to Dry Eye Disease . Invest. Ophthalmol. Vis. Sci. 2003;44(13):2490.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: We have previously shown (Narayanan S, ARVO Abstract #2624, 2001) that the antimicrobial peptide human ß-defensin (hBD)-2 is present in the conjunctival epithelium of moderately dry eye patients but not in normal control subjects, while hBD-1 and 3 are constitutively expressed. Recent evidence demonstrates increased proinflammatory cytokine activity in dry eye disease. Therefore, we investigated if proinflammatory cytokines can modulate the expression of hBD- 1, 2 and 3 by conjunctival epithelial cells in culture. Methods:Two conjunctival cell lines (Chang and NHC) and primary cultured conjunctival epithelial cells were treated with 10 ng/ml interleukin (IL)-1ß, tumor necrosis factor (TNF)-α, IL-1ß+TNF-α or interferon (IFN)-γ (40 ng/ml) for 24 hours. RT-PCR was performed to detect mRNA for hBD-1, 2 and 3. hBD-1 and -2 protein secretion was detected by immunoblotting. The effect of treatment duration (2-24 hours) and concentration (0.1-100 ng/ml) of IL-1ß on hBD-2 expression was also studied. Results:RT-PCR demonstrated constitutive expression of hBD-1 and 3. hBD-2 mRNA was not expressed at baseline by the cell lines (n = 3) and was only weakly expressed by primary cultured cells (n = 2). Upregulation of hBD-2 mRNA was observed following IL-1ß, TNF-α, IL-1ß+TNF-α or IFN-γ treatment. There was no change in the expression of hBD-1 and 3 with cytokine treatment. Upregulation of hBD-2 mRNA was detected as early as 2 hours after treatment with 10 ng/ml IL-1ß and was maximal at 12 hours (n=2 cell lines; n=1 primary cells). 0.1 ng/ml of IL-1ß (for 24 hours) was sufficient to upregulate hBD-2 mRNA, with peak expression occurring with 10 ng/ml (n=2 cell lines; n=1 primary cells). hBD-1 protein was constitutively secreted, while hBD-2 secretion was upregulated in a pattern corresponding to the RT-PCR data. Conclusions:Proinflammatory cytokines induce the expression of hBD-2 by conjunctival epithelial cells. The upregulation of hBD-2 observed in moderately dry eye subjects in our previous study may be mediated by proinflammatory cytokines and would provide additional anti-microbial protection to the compromised ocular surface.

Keywords: conjunctiva • cytokines/chemokines • cornea: tears/tear film/dry eye 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×